echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Lupus immunomodulation research based on large cohort and single-cell RNA sequencing technology

    Lupus immunomodulation research based on large cohort and single-cell RNA sequencing technology

    • Last Update: 2022-09-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    To accompany the lupus advocacy, we share here two innovative studies that have brought new insights into systemic lupus erythematosus (SLE) to understand genomic differences in circulating immune cells and cell-type-specific genes Express the relationship between features


    How is a disease diagnosed and treated differently in every patient? Systemic lupus erythematosus (SLE) is one such highly heterogeneous autoimmune disease that causes widespread inflammation and tissue damage in affected organs, including joints, skin, brain, lungs, kidneys, and blood vessels (1)


    Despite the variety of clinical manifestations of lupus, two recent papers by Perez et al.


    Comprehensive census of lupus immune cells

    Previous studies have identified a key culprit in lupus pathogenesis as aberrant T-cell biology, "which aggravates inflammation by secreting pro-inflammatory cytokines, helps B cells produce autoantibodies, and maintains disease through the accumulation of autoreactive memory T cells.


    Perez et al.


    By analyzing the CD8+ T cell compartment of SLE cases, they observed that the proportion of CD8GZMH cells expressing granzymes was significantly increased compared to controls


    Perez et al.



    When Population Genetics Meets Single-Cell RNA-seq

    Having defined cell-type-specific expression signatures in the peripheral immune profiles of lupus patients and healthy subjects, the research team hopes to integrate their results with a deeper biology: the genome


    Their approach used genotyping data that generated reads of expressed quantitative trait loci (eQTLs), the loci that explain differences in mRNA expression levels


    Among the eight most predominant cell types in SLE samples, Perez et al.


    Yazar et al.


    These two analyses underscore the potential of combining genomic and transcriptomic technologies to not only inform each other, but to more deeply annotate disease-associated risk loci, mapping not only genetic variants to disease-causing genes, but also to specific cell types and pathways that drive disease


    Welcome to download 10x Genomics' latest brochure "Breaking New Frontiers in Immunology Research"

    references:

    1.


    2.


    3.


    4.
    Sumida T and Hafler D.
    Population genetics meets single-cell sequencing.
    Science 376: 134–135 (2022).
    doi: 10.
    1126/science.
    abq0426

    5.
    Yazar S, et al.
    Single-cell eQTL mapping identifies cell type-specific genetic control of autoimmune disease.
    Science 376: eabf3041 (2022).
    doi: 10.
    1126/science.
    abf3041

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.